Telix acquires ITM for $1.65 billion: a radiopharmaceutical giant is born
Telix Pharmaceuticals has signed a deal worth at least $1.65 billion to merge with ITM Isotope Technologies Munich, the world's leading producer of therapeutic radioisotopes. The combined company is targeting pro forma revenues of over… read more...


















